As biotech stocks knife under their ‘Hillary’ low, analysts still say buy ’em

Biotech stocks have dived to levels last seen in late 2014, in another sign of how the new year has hammered riskier plays.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.